Evidence map›Paper›PMID 38188321›Full record

ArticleJournal of cardiology cases2024

Recurrent left ventricular thrombus due to essential thrombocythemia complicated by COVID-19.

Kenta Matsui, Tadashi Kitamura, Shinzo Torii, Toshiaki Mishima, Fumiaki Shikata, Masaomi Fukuzumi, Shunichiro Fujioka, Haruna Araki, Rihito Horikoshi, Yoshimi Tamura and 2 more

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiology cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kenta MatsuiDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Tadashi KitamuraDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Shinzo ToriiDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Toshiaki MishimaDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Fumiaki ShikataDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Masaomi FukuzumiDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Shunichiro FujiokaDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Haruna ArakiDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Rihito HorikoshiDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Yoshimi TamuraDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Hisaya MoriDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Kagami MiyajiDepartment of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Kitasato University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essential thrombocythemia is a risk factor for thrombosis and hemorrhage. During the perioperative period of cardiac surgery, the risk of thrombosis and hemorrhage increases. Coronavirus disease 2019 (COVID-19) is also associated with thrombosis. We present the case of a 69-year-old man with essential thrombocythemia complicated by COVID-19 who developed a left ventricular thrombus. We performed thrombectomy, but the patient developed recurrent left ventricular thrombus 8 days after surgery. Emergency redo thrombectomy was performed followed by aggressive blood-thinning therapy. The postoperative course was complicated by cardiac tamponade requiring surgical drainage 8 days after the second surgery. The patient was discharged home 25 days after the second operation without any complications. Learning objective: Left ventricular thrombus is a rare but fatal complication associated with essential thrombocythemia. COVID-19 has also been reported to cause coagulopathy. This case suggested that after surgery for left ventricular thrombus complicated by multiple risk factors including essential thrombocythemia and COVID-19, aggressive blood-thinning therapy with combination of anticoagulation, antiplatelet, and metabolic antagonist may help prevent recurrent thrombosis.

Indexed as

COVID-19Essential thrombocythemiaLeft ventricular thrombus

Identifiers

PMID38188321
PMCPMC10770075
OpenAlexW4387610459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.